Millennium Management LLC Has $234,000 Position in Astrana Health, Inc. (NASDAQ:ASTH)

Millennium Management LLC cut its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 56.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 7,433 shares of the company's stock after selling 9,700 shares during the period. Millennium Management LLC's holdings in Astrana Health were worth $234,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. State of New Jersey Common Pension Fund D grew its holdings in shares of Astrana Health by 25.4% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 51,287 shares of the company's stock valued at $1,617,000 after purchasing an additional 10,389 shares during the period. Truist Financial Corp acquired a new stake in Astrana Health during the fourth quarter worth approximately $315,000. Handelsbanken Fonder AB raised its holdings in Astrana Health by 4.7% during the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock worth $281,000 after purchasing an additional 400 shares in the last quarter. Hussman Strategic Advisors Inc. purchased a new position in shares of Astrana Health during the fourth quarter worth approximately $1,986,000. Finally, Olympiad Research LP purchased a new position in shares of Astrana Health during the fourth quarter worth approximately $287,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Truist Financial decreased their target price on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research report on Tuesday, March 18th. Stifel Nicolaus dropped their target price on shares of Astrana Health from $70.00 to $56.00 and set a "buy" rating for the company in a research report on Thursday, February 20th. Barclays started coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price objective for the company. Bank of America decreased their price target on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, March 4th. Finally, Robert W. Baird decreased their price objective on shares of Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Price Performance

Astrana Health stock traded down $0.60 during midday trading on Friday, hitting $25.75. The company's stock had a trading volume of 212,743 shares, compared to its average volume of 293,274. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The stock's 50-day moving average price is $28.71 and its 200-day moving average price is $32.32. Astrana Health, Inc. has a 12 month low of $23.12 and a 12 month high of $63.20. The company has a market capitalization of $1.44 billion, a PE ratio of 19.81, a price-to-earnings-growth ratio of 1.37 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09). The company had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. Astrana Health's quarterly revenue was up 53.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.31 EPS. Analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.